Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Hypovase tablets B.D. starter pack
0205040S0BBAEAA
|
Hypovase | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Idarucizumab 2.5g/50ml solution for infusion vials
0208040A0AAAAAA
|
Idarucizumab | Idarucizumab | Cardiovascular System | No data available |
|
Ilomedin 100micrograms/1ml solution for infusion ampoules
0205010V0BCAAAA
|
Ilomedin | Iloprost | Cardiovascular System | No data available |
|
Iloprost 100micrograms/1ml solution for infusion ampoules
0205010V0AAAAAA
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 10micrograms/1ml neb liq ampoules with device
0205010V0AAAEAE
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 20micrograms/1ml neb liq ampoules with device
0205010V0AAAFAF
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 20micrograms/1ml nebuliser liquid ampoules
0205010V0AAADAD
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 50micrograms/0.5ml solution for infusion ampoules
0205010V0AAABAB
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Imazin XL forte tablets
0206010W0BBABAB
|
Imazin | Isosorbide mononitrate with aspirin | Cardiovascular System | No data available |
|
Imazin XL tablets
0206010W0BBAAAA
|
Imazin | Isosorbide mononitrate with aspirin | Cardiovascular System | No data available |
|
Imo LA 50mg capsules
0206010K0CLAAAF
|
Imo | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Inderal 10mg tablets
0204000R0BGAAAH
|
Inderal | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Inderal 1mg/1ml solution for injection ampoules
0204000R0BGAEAC
|
Inderal | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Inderal 80mg tablets
0204000R0BGACAK
|
Inderal | Propranolol hydrochloride | Cardiovascular System | No data available |
|
Inderetic 80mg/2.5mg capsules
0204000Q0BBAAAA
|
Inderetic | Propranolol hydrochloride with diuretic | Cardiovascular System | No data available |
|
Inderex 160mg/5mg modified-release capsules
0204000Q0BCAAAB
|
Inderex | Propranolol hydrochloride with diuretic | Cardiovascular System | No data available |
|
Innohep 2,500units/0.25ml inj pre-filled syringes
0208010W0BCAKAQ
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 20,000units/2ml solution for injection vials
0208010W0BCAJAN
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 3,500units/0.35ml inj pre-filled syringes
0208010W0BCAHAL
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 4,500units/0.45ml inj pre-filled syringes
0208010W0BCAIAM
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Innohep 40,000units/2ml solution for injection vials
0208010W0BCACAF
|
Innohep | Tinzaparin sodium | Cardiovascular System | No data available |
|
Inositol nicotinate 1g/5ml oral suspension
0206040AFAAAHAH
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 1g/5ml oral suspension sugar free
0206040AFAAACAC
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 500mg tablets
0206040AFAAAAAA
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
|
Inositol nicotinate 750mg tablets
0206040AFAAABAB
|
Nicotinic acid derivatives | Nicotinic acid derivatives | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.